Literature DB >> 10887104

Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.

L Quintanilla-Martinez1, S Kumar, F Fend, E Reyes, J Teruya-Feldstein, D W Kingma, L Sorbara, M Raffeld, S E Straus, E S Jaffe.   

Abstract

This study describes the clinicopathologic features of 5 patients who developed a fulminant Epstein-Barr virus (EBV)-positive clonal T-cell lymphoproliferative disorder (LPD) after acute EBV infection. One additional patient developed a similar disorder in the setting of long-standing chronic active EBV infection. Detailed immunophenotyping, in situ hybridization for EBV early RNA-1 (EBER1) and polymerase chain reaction (PCR) analyses for immunoglobulin (Ig) heavy chain and T-cell receptor (TCR)-gamma gene rearrangements were performed on paraffin-embedded tissue from all patients. In addition, EBV strain typing and detection of the characteristic 30-bp deletion of the latent membrane protein-1 (LMP-1) gene were performed by PCR. Controls included 8 cases of uncomplicated infectious mononucleosis (IM). Patients included 4 males and 2 females with a median age of 18 years (2-37 years). Three patients were Mexican, 2 were white, and 1 was of Asian descent. All presented with fever, hepatosplenomegaly, and pancytopenia; 5 were previously healthy, but had a clinical history of a recent viral-like upper respiratory illness (1 week to 2 months), and 1 patient had documented chronic active EBV infection for 7 years. Serologic data for EBV were incomplete but titers were either negative or only modestly elevated in 3 cases. In 1 case serology was consistent with severe chronic active EBV infection. In the remaining 2 cases serologic studies were not performed. All patients died within 7 days to 8 months of presentation with T-cell LPD. On histologic examination, the liver and spleen showed prominent sinusoidal and portal lymphoid infiltrates of CD3(+), beta F1(+), EBER1(+) T cells lacking significant cytologic atypia. Two cases were CD4(+), 2 cases were CD8(+), and 2 cases had admixed CD4(+) and CD8(+) cells without clear subset predominance. All were TIA-1(+), CD56(-). Only rare B cells were noted. Marked erythrophagocytosis was present. Molecular analysis revealed identical T-cell clones in 2 or more sites (liver, spleen, lymph node) in 5 cases. All patients carried type A EBV; 4 cases had wild-type EBV-LMP, and 2 showed the 30-bp deletion. This fulminant T-cell LPD after acute/chronic EBV infection is characterized by hepatosplenomegaly, often without significant lymphadenopathy, fever, liver failure, pancytopenia, and erythrophagocytosis indicative of a hemophagocytic syndrome. EBV serology may be misleading, with lack of elevated titers. The presence of an EBER1(+) T-cell infiltrate with scant B cells should alert one to this diagnosis. Although cytologic atypia is minimal, studies for T-cell clonality confirm the diagnosis. (Blood. 2000;96:443-451)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10887104

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  61 in total

Review 1.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

2.  Fatal primary Epstein-Barr virus infection due to clonal CD8+ T-lymphocyte proliferation in an immunocompetent adult.

Authors:  Naoko Satoh; Tadashi Koike; Hidekichi Takato; Masahiro Fujiwara; Iwao Emura; Hirokazu Kaneganed
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

Review 3.  New targets of therapy in T-cell lymphomas.

Authors:  Jack Erter; Lapo Alinari; Kamruz Darabi; Metin Gurcan; Ramiro Garzon; Guido Marcucci; Mark A Bechtel; Henry Wong; Pierluigi Porcu
Journal:  Curr Drug Targets       Date:  2010-04       Impact factor: 3.465

4.  Defining the elusive boundaries of chronic active Epstein-Barr virus infection.

Authors:  Sebastian Fernandez-Pol; Oscar Silva; Yasodha Natkunam
Journal:  Haematologica       Date:  2018-06       Impact factor: 9.941

Review 5.  Infectious mononucleosis mimicking malignant T-cell lymphoma in the nasopharynx: a case report and review of the literature.

Authors:  Hong-Lin He; Ming-Chung Wang; Wan-Ting Huang
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

6.  Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disorders of childhood with fulminant leukocytosis and tumor lysis: a case report with autopsy findings.

Authors:  Sachie Wada; Takayuki Suzuki; Koichi Kitazume; Akira Fujita; Seiichiro Shimizu
Journal:  Int J Hematol       Date:  2017-12-07       Impact factor: 2.490

7.  Nodular regenerative hyperplasia in common variable immunodeficiency.

Authors:  Ivan J Fuss; Julia Friend; Zhiqiong Yang; Jian Ping He; Lubna Hooda; James Boyer; Liqiang Xi; Mark Raffeld; David E Kleiner; Theo Heller; Warren Strober
Journal:  J Clin Immunol       Date:  2013-02-19       Impact factor: 8.317

Review 8.  Viral-associated lymphoid proliferations.

Authors:  Stefania Pittaluga
Journal:  Semin Diagn Pathol       Date:  2013-03-26       Impact factor: 3.464

9.  Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Authors:  J I Cohen; H Kimura; S Nakamura; Y-H Ko; E S Jaffe
Journal:  Ann Oncol       Date:  2009-06-10       Impact factor: 32.976

10.  Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.

Authors:  Ren-Ching Wang; Sheng-Tsung Chang; Yen-Chuan Hsieh; Wan-Ting Huang; Jeng-Dong Hsu; Chih-En Tseng; Ming-Chung Wang; Wei-Shou Hwang; John Wang; Shih-Sung Chuang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.